The Centers for Disease Control and Prevention (CDC) 2007 Institute on Critical Issues in Health Laboratory
Practice: Managing for Better Health (2007 Institute) was designed to bring together national leaders in laboratory medicine, experts on health care policy and quality, and representatives from multiple stakeholder groups for high-quality laboratory services to develop an action plan for change. An underlying assumption motivating the 2007 Institute was that the current state of laboratory medicine practice may be viewed as supporting less than optimal patient care. It is well recognized that pathologists and other laboratory medicine personnel work extremely hard and have produced remarkable achievements, although the potential for further improvement is still present.
The 2007 Institute focused on three themes: (1) advancing collaborative care, or ways to enhance communication and collaboration of providers of laboratory services and consumers, other providers and users of laboratory services, and payers; (2) measures of quality, or ways to define quality parameters that will link laboratory service performance with patient outcomes; and (3) preparing for the future, or ways that laboratory medicine is expected to contribute to the future of health care. The goals of the 2007 Institute were to lay the foundation for strategies not only to identify and plan immediate actions to optimally use laboratory medicine to improve services but also to develop a 5-to 10-year strategic plan to actively address the broader roles that laboratory medicine must assume to ensure safe and effective care and improved patient outcomes for all Americans. The key outputs of the 2007 Institute were designed to be the collective recommendations of the theme groups for a multiyear strategic plan for the field of laboratory medicine.
Prior Work Used to Inform the 2007 Institute
The 2007 Institute was the most recent in a series of CDC initiatives aimed at investigating the state of laboratory medicine and exploring means of improving practice. During the 1980s and 1990s, the CDC convened 5 meetings to build stakeholder coalitions, to facilitate strategic planning, and to formulate recommendations on laboratoryrelated issues. 1 These meetings focused on the impact of alternative reimbursement methods on laboratory practice (1984), public health laboratory safety management (1985) , quality management of laboratory test results in a changing health care environment (1986), quality improvement of health management through clinician and laboratory teamwork (1989), and evaluation of the frontiers of laboratory practice research (1995) .
The CDC convened the Quality Institute Conference 2003 that targeted a number of quality and patient safety issues. Other CDC initiatives in 2005 included the evaluation of quality indicators and an inventory of laboratory patient safety initiatives with input from the Clinical Laboratory Management Association and the Institute for Quality in Laboratory Medicine.
Institute Structure
The 2007 Institute was convened on September 24-26, 2007, in Atlanta, GA, and was structured as an invitationonly meeting, composed of information presentation sessions that all invitees attended zAppendix 1z and 3 breakout groups, each group composed of approximately one third of all invitees. 2 For each of the 3 themes, 2007 Institute participants defined the current and ideal states of laboratory service practice, identified gaps between the current and ideal states, and suggested action plans necessary to address the gaps currently separating participants' perceptions of the current and ideal states of laboratory medicine practice.
A total of approximately 100 invitees and CDC staff attended the 2007 Institute, and these participants represented a variety of stakeholders, including pathologists, multiple other laboratory personnel, laboratory medicine personnel representatives from particular professional organizations (eg, American Society for Clinical Laboratory Science), nonpathologist physicians (mostly primary care clinicians), representatives from funding agencies (eg, Agency for Healthcare Research and Quality), representatives from payer organizations, patient advocates, health information technology experts, health services researchers, laboratory administrators, and representatives from nationally recognized health care quality organizations.
Methods and Materials Used to Synthesize the Summary
The ideal outcomes to be developed by Institute attendees participating in discussion groups focused on each of the three Institute themes: (1) identification of unmet challenges, (2) identification of steps to meet challenges, and (3) launching an agenda for change. The following is a summary of the information relevant to these outcomes presented in tabular form. Four major information sources were used to synthesize this summary: (1) written background and Institute syllabus materials provided to invitees before or at the 2007 Institute (eg, the Lewin Group and National Quality Forum reports), 3, 4 (2) transcripts of audiotapes obtained by researchers funded by the CDC to actively participate in the 2007 Institute as a first step in development of a laboratory medicine research agenda, (3) handwritten field notes written by the 2 of us (D.M.G. and S.S.R.) during the course of the Institute, and (4) examination of all written notes from the breakout groups.
In alignment with a desire to present the information emanating from the Institute in a nationally meaningful context, the laboratory medicine quality gaps and potential action plans were classified into one of the 6 Institute of Medicine (IOM) health care domains: safety, effectiveness, patient centeredness, timeliness, efficiency, and equity. It is evident that many of the gaps articulated during the Institute could fit under more than one of the IOM characteristics. It also is evident after examining the quality gaps and suggested action plans to address the gaps zTable 1z, zTable 2z, zTable 3z, zTable 4z, zTable 5z, and zTable 6z that either or both of the stated gaps and correlating action plans at least imply root causes for quality failures. However, it was not an explicit charge of 2007 Institute invitees to perform formal root cause analysis on the identified quality gaps. Some root causes may have been relatively evident, and they appear in the following summary. However, some of the quality gaps articulated during the 2007 Institute were complex, involving organizational, economic, and political causes that could not be sufficiently explored during the discussion sessions.
The summary information was validated independently by all authors attending the 2007 Institute and by CDC project members and 2007 Institute staff.
Summary
A subgroup of the 2007 Institute attendees was invited by the CDC to participate in a discussion aimed at articulating feasible "next steps" that attendees, others in the laboratory community, and other stakeholders may and should pursue, based on the information obtained and discussed 
